Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bal Raj, Bhandari"'
Autor:
Eric J, Lawitz, Bal Raj, Bhandari, Peter J, Ruane, Anita, Kohli, Eliza, Harting, Dora, Ding, Jen-Chieh, Chuang, Ryan S, Huss, Chuhan, Chung, Robert P, Myers, Rohit, Loomba
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, vol 21, iss 1
Background & aimsPatients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) are at high risk of morbidity and mortality. We previously found that a combination of the farnesoid X receptor agonist cilofexor (CILO) and the acetyl-CoA ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::929b2cef2b51a962b092040436babe79
https://escholarship.org/uc/item/1c44j6bg
https://escholarship.org/uc/item/1c44j6bg
Autor:
Mazen Noureddin, Eric Lawitz, Naim Alkhouri, Robert Jenders, Douglas Denham, Bal Raj Bhandari, Christopher Jones, Cara H. Nelson, Tonya Marmon, Swapna Shenvi, Hiba Graham, Daria Crittenden, Erin Quirk, Diana Chung
Publikováno v:
Journal of Hepatology. 77:S731-S732
Autor:
Silvio Danese, Barrett G. Levesque, Brian G. Feagan, Alina Jucov, Bal Raj Bhandari, Rish K. Pai, Kristen Taylor Meadows, Brian J. Kirby, Jean‐Marie Bruey, Allan Olson, Robin Osterhout, Courtney Van Biene, Julia Ford, Richard Aranda, Kartik Raghupathi, William J. Sandborn
Publikováno v:
Alimentary pharmacologytherapeutics. 55(4)
Epithelial barrier dysfunction contributes to a dysregulated intestinal immune response in ulcerative colitis (UC). GB004 is an orally administered, small molecule, gut-targeted stabiliser of hypoxia-inducible factor-1α, a transcription factor with
Autor:
Rohit Loomba, Mazen Noureddin, Kris Kowdley, Anita Kohli, Aasim Sheikh, Guy Neff, Bal Raj Bhandari, Nadege T. Gunn, Stephen Caldwell, Zachary Goodman, Ilan Wapinski, Murray Resnick, Andrew Beck, Dora Ding, Catherine Jia, Ryan Huss, Chuhan Chung, Mani Subramanian, Robert Myers, Keyur Patel, Brian Borg, Reem Ghalib, Heidi Kabler, John Poulos, Ziad H. Younes, Magdy Elkhashab, Tarek Hassanein, Rajalakshmi Iyer, Peter Ruane, Mitchell Shiffman, Simone Strasser, Vincent Wai-Sun Wong, Naim Alkhouri
Publikováno v:
Journal of Hepatology. 73:S116-S117
Autor:
Bal Raj Bhandari, Jeffrey Cehelsky, Yan Zheng, Mark Wingertzahn, Norma Palma, Robert S Mittleman
Publikováno v:
Journal of Hepatology. 73:S699
Autor:
Yunsheng, Yang, Jingyuan, Fang, Xiaozhong, Guo, Ning, Dai, Xizhong, Shen, Youlin, Yang, Jing, Sun, Bal Raj, Bhandari, David S, Reasner, Jacquelyn A, Cronin, Mark G, Currie, Jeffrey M, Johnston, Peter, Zeng, Niwat, Montreewasuwat, George Zhijian, Chen, Sam, Lim
Publikováno v:
Journal of gastroenterology and hepatology. 33(5)
Linaclotide is a guanylate cyclase-C agonist approved in multiple countries to treat irritable bowel syndrome with constipation (IBS-C). China has unmet need for well-tolerated therapy that is effective in treating both bowel and abdominal symptoms o
Autor:
Catherine A.M. Stedman, Yanni Zhu, Sergio Borgia, Bernard Willems, Bal Raj Bhandari, Edward Gane, Kosh Agarwal, Jordan J. Feld, Evguenia S. Svarovskaia, Hadas Dvory-Sobol, Alexander J. Thompson, Gregory J. Dore, Graham R. Foster, Tarik Asselah, Diana M. Brainard, John G. McHutchison, Ronald Nahass, G. Mani Subramanian, Thomas Berg, Luisa M. Stamm, Ira M. Jacobson, Eric Lawitz, M. Davis, Stephen D. Shafran, Peter Ruane, Robert H. Hyland, Kimberly A. Workowski, Stuart K. Roberts, Brian L. Pearlman, Norbert Bräu
Publikováno v:
Gastroenterology. 153(1)
Background & Aims Patients with chronic hepatitis C virus (HCV) infection have high rates of sustained virologic response (SVR) after 12 weeks of treatment with the nucleotide polymerase inhibitor sofosbuvir combined with the NS5A inhibitor velpatasv
Autor:
Peter, Ferenci, David, Bernstein, Jacob, Lalezari, Daniel, Cohen, Yan, Luo, Curtis, Cooper, Edward, Tam, Rui T, Marinho, Naoky, Tsai, Anders, Nyberg, Terry D, Box, Ziad, Younes, Pedram, Enayati, Sinikka, Green, Yaacov, Baruch, Bal Raj, Bhandari, Florin Alexandru, Caruntu, Thomas, Sepe, Vladimir, Chulanov, Ewa, Janczewska, Giuliano, Rizzardini, Judit, Gervain, Ramon, Planas, Christophe, Moreno, Tarek, Hassanein, Wangang, Xie, Martin, King, Thomas, Podsadecki, K Rajender, Reddy, J, Yozviak
Publikováno v:
The New England journal of medicine. 370(21)
Background The interferon-free regimen of ABT-450 with ritonavir (ABT-450/r), ombitasvir, and dasabuvir with or without ribavirin has shown efficacy in inducing a sustained virologic response in a phase 2 study involving patients with hepatitis C vir
Autor:
Samuel H. Sigal, Arun J. Sanyal, Kunal Merchant, Nathan M. Bass, Fred Poordad, Muhammad Y. Sheikh, Ravikumar Vemuru, Audrey L. Shaw, Enoch Bortey, Todd Frederick, Kevin D. Mullen, Shirley Huang, Bal Raj Bhandari, William P. Forbes
Publikováno v:
American Journal of Gastroenterology. 104:S136